SQZ Biotechnologies Company
OTC: SQZB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Howard Bernstein
- Employees
- 53
- Headquarters
- Watertown, United States
- IPO year
- 2020
- Market cap
- $707.8K
- Website
- https://www.sqzbiotech.com
Loading SQZB…
Loading profile data…Frequently asked questions about SQZB
What does SQZ Biotechnologies Company (SQZB) do?
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, infectious diseases, and other serious conditions in Massachusetts. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combina...
Where does SQZB trade?
SQZ Biotechnologies Company (SQZB) trades on the Other OTC.
What sector is SQZB in?
SQZ Biotechnologies Company (SQZB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of SQZ Biotechnologies Company?
Howard Bernstein is the chief executive officer of SQZ Biotechnologies Company (SQZB).
Where is SQZ Biotechnologies Company headquartered?
SQZ Biotechnologies Company is headquartered in United States.
Does SQZB pay a dividend?
SQZ Biotechnologies Company (SQZB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SQZB go public?
SQZ Biotechnologies Company (SQZB) completed its initial public offering in 2020.